SBI-0640756 is primarily used in research settings to study its potential therapeutic effects, particularly in the field of oncology. It has been investigated for its role in inhibiting specific protein-protein interactions that are crucial for cancer cell survival and proliferation. Researchers are exploring its efficacy in preclinical models to determine its potential as a targeted therapy for certain types of cancers. Additionally, it is being examined for its ability to enhance the effectiveness of existing cancer treatments when used in combination therapies. Its application extends to understanding molecular pathways involved in disease progression, which could lead to the development of novel treatment strategies.